These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33350326)

  • 21. Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.
    Lindsjö M
    Scand J Urol Nephrol Suppl; 1989; 119():1-53. PubMed ID: 2669121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early onset of stone diseases and primary hyperoxaluria.
    Topaloglu R; Bakkaloglu A; Saatci U; Besbas N
    Paediatr Indones; 1990; 30(1-2):54-8. PubMed ID: 2284120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Idiopathic calcium nephrolithiasis with pure calcium oxalate composition: clinical correlates of the calcium oxalate dihydrate/monohydrate (COD/COM) stone ratio.
    Guerra A; Ticinesi A; Allegri F; Pinelli S; Aloe R; Meschi T
    Urolithiasis; 2020 Jun; 48(3):271-279. PubMed ID: 31506762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible ethnic associations in primary hyperoxaluria type-III-associated HOGA1 sequence variants.
    Abid A
    Mol Biol Rep; 2021 Apr; 48(4):3841-3844. PubMed ID: 33948853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What Factors Drive Staghorn
    Winoker JS; Bamberger JN; Chandhoke RA; Atallah W; Gupta M
    J Endourol; 2019 Nov; 33(11):954-959. PubMed ID: 31436119
    [No Abstract]   [Full Text] [Related]  

  • 26. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers.
    Siener R; Ebert D; Nicolay C; Hesse A
    Kidney Int; 2003 Mar; 63(3):1037-43. PubMed ID: 12631085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A porcine model of calcium oxalate kidney stone disease.
    Mandel NS; Henderson JD; Hung LY; Wille DF; Wiessner JH
    J Urol; 2004 Mar; 171(3):1301-3. PubMed ID: 14767337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular degradation of 4-hydroxy-2-oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3.
    MacDonald JR; Huang AD; Loomes KM
    FEBS Lett; 2016 May; 590(10):1467-76. PubMed ID: 27096395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population.
    Wang W; Liu Y; Kang L; He R; Song J; Li Y; Li J; Yang Y
    Kidney Blood Press Res; 2019; 44(4):743-753. PubMed ID: 31401635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.
    Belostotsky R; Pitt JJ; Frishberg Y
    J Mol Med (Berl); 2012 Dec; 90(12):1497-504. PubMed ID: 22729392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extreme diet without calcium may lead to hyperoxaluria and kidney stone recurrence-A case study.
    Šálek T
    J Clin Lab Anal; 2020 Dec; 34(12):e23512. PubMed ID: 32761639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of patients with idiopathic calcium phosphate and calcium oxalate stones.
    Gault MH; Chafe LL; Morgan JM; Parfrey PS; Harnett JD; Walsh EA; Prabhakaran VM; Dow D; Colpitts A
    Medicine (Baltimore); 1991 Nov; 70(6):345-59. PubMed ID: 1956278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium stone disease: a multiform reality.
    Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
    Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diet to reduce mild hyperoxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study.
    Nouvenne A; Meschi T; Guerra A; Allegri F; Prati B; Fiaccadori E; Maggiore U; Borghi L
    Urology; 2009 Apr; 73(4):725-30, 730.e1. PubMed ID: 19193409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissecting the genetic basis of kidney tubule response to hyperoxaluria using chromosome substitution strains.
    Wiessner JH; Garrett MR; Roman RJ; Mandel NS
    Am J Physiol Renal Physiol; 2009 Aug; 297(2):F301-6. PubMed ID: 19493966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperoxaluric calcium nephrolithiasis.
    Asplin JR
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):927-49. PubMed ID: 12474639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late diagnosis of primary hyperoxaluria type III.
    Richard E; Blouin JM; Harambat J; Llanas B; Bouchet S; Acquaviva C; de la Faille R
    Ann Clin Biochem; 2017 May; 54(3):406-411. PubMed ID: 27742850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two Novel HOGA1 Splicing Mutations Identified in a Chinese Patient with Primary Hyperoxaluria Type 3.
    Wang X; Zhao X; Wang X; Yao J; Zhang F; Lang Y; Tuffery-Giraud S; Bottillo I; Shao L
    Am J Nephrol; 2015; 42(1):78-84. PubMed ID: 26340091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.